These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36031157)

  • 21. Production of the short peptide surfactant DAMP4 from glucose or sucrose in high cell density cultures of Escherichia coli BL21(DE3).
    Bruschi M; Krömer JO; Steen JA; Nielsen LK
    Microb Cell Fact; 2014 Aug; 13():99. PubMed ID: 25134850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Framework for the rapid optimization of soluble protein expression in Escherichia coli combining microscale experiments and statistical experimental design.
    Islam RS; Tisi D; Levy MS; Lye GJ
    Biotechnol Prog; 2007; 23(4):785-93. PubMed ID: 17592858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of T7 RNA polymerase transcription enhances pET-based recombinant protein production in Escherichia coli BL21 (DE3) by suppressing autolysis.
    Sun XM; Zhang ZX; Wang LR; Wang JG; Liang Y; Yang HF; Tao RS; Jiang Y; Yang JJ; Yang S
    Biotechnol Bioeng; 2021 Jan; 118(1):153-163. PubMed ID: 32897579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant production of active Streptococcus pneumoniae CysE in E. coli facilitated by codon optimized BL21(DE3)-RIL and detergent.
    Verma D; Antil M; Gupta V
    Prep Biochem Biotechnol; 2019; 49(4):368-374. PubMed ID: 30734630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical manufacturing of recombinant human interleukin 15. I. Production cell line development and protein expression in E. coli with stop codon optimization.
    Vyas VV; Esposito D; Sumpter TL; Broadt TL; Hartley J; Knapp GC; Cheng W; Jiang MS; Roach JM; Yang X; Giardina SL; Mitra G; Yovandich JL; Creekmore SP; Waldmann TA; Zhu J
    Biotechnol Prog; 2012; 28(2):497-507. PubMed ID: 22162520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulating the T7 RNA polymerase expression in E. coli BL21 (DE3) to provide more host options for recombinant protein production.
    Du F; Liu YQ; Xu YS; Li ZJ; Wang YZ; Zhang ZX; Sun XM
    Microb Cell Fact; 2021 Sep; 20(1):189. PubMed ID: 34565359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimization of extracellular truncated staphylococcal protein A expression in Escherichia coli BL21 (DE3).
    Rigi G; Mohammadi SG; Arjomand MR; Ahmadian G; Noghabi KA
    Biotechnol Appl Biochem; 2014; 61(2):217-25. PubMed ID: 24033345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-level expression of Falcipain-2 in Escherichia coli by codon optimization and auto-induction.
    Sarduy ES; Muñoz AC; Trejo SA; de los A Chavéz Planes M
    Protein Expr Purif; 2012 May; 83(1):59-69. PubMed ID: 22450163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The toxicity of recombinant proteins in Escherichia coli: a comparison of overexpression in BL21(DE3), C41(DE3), and C43(DE3).
    Dumon-Seignovert L; Cariot G; Vuillard L
    Protein Expr Purif; 2004 Sep; 37(1):203-6. PubMed ID: 15294299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression and optimization of anti-AFB1 scFv in Escherichia colil].
    Yang L; Zhang Y; Ding H; Wang L; Chen W; Zhang H
    Wei Sheng Wu Xue Bao; 2009 Jul; 49(7):880-8. PubMed ID: 19873751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of statistical approaches used for the optimization of soluble protein expression in Escherichia coli.
    Papaneophytou C; Kontopidis G
    Protein Expr Purif; 2016 Apr; 120():126-37. PubMed ID: 26721705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization and optimization of ArtinM lectin expression in Escherichia coli.
    Pranchevicius MC; Oliveira LL; Rosa JC; Avanci NC; Quiapim AC; Roque-Barreira MC; Goldman MH
    BMC Biotechnol; 2012 Aug; 12():44. PubMed ID: 22857259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Examination of alternate codon bias solutions for expression and purification of recombinant mechano-growth factor in Escherichia coli.
    Feng J; Wan R; Yi Q; He L; Yang L; Tang L
    Biotechnol Appl Biochem; 2015; 62(5):690-8. PubMed ID: 25345350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of solubility in Escherichia coli and purification of an aminotransferase from Sphingopyxis sp. MTA144 for deamination of hydrolyzed fumonisin B(1).
    Hartinger D; Heinl S; Schwartz HE; Grabherr R; Schatzmayr G; Haltrich D; Moll WD
    Microb Cell Fact; 2010 Aug; 9():62. PubMed ID: 20718948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving the soluble expression and purification of recombinant human stem cell factor (SCF) in endotoxin-free Escherichia coli by disulfide shuffling with persulfide.
    Ueda T; Akuta T; Kikuchi-Ueda T; Imaizumi K; Ono Y
    Protein Expr Purif; 2016 Apr; 120():99-105. PubMed ID: 26724416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engineering Escherichia coli BL21(DE3) derivative strains to minimize E. coli protein contamination after purification by immobilized metal affinity chromatography.
    Robichon C; Luo J; Causey TB; Benner JS; Samuelson JC
    Appl Environ Microbiol; 2011 Jul; 77(13):4634-46. PubMed ID: 21602383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of active human C1 inhibitor serpin domain in Escherichia coli.
    Lamark T; Ingebrigtsen M; Bjørnstad C; Melkko T; Mollnes TE; Nielsen EW
    Protein Expr Purif; 2001 Jul; 22(2):349-58. PubMed ID: 11437612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Optimization of expression conditions of an induction strategy for improving liver targeted interferon (IFN-CSP) production in E. coli].
    Huang Y; Lu X; Wang J; Jin X; Zhu J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2014 Apr; 31(2):432-8. PubMed ID: 25039155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-level expression and purification of soluble bioactive recombinant human heparin-binding epidermal growth factor in Escherichia coli.
    Khalili M; Soleyman MR; Baazm M; Beyer C
    Cell Biol Int; 2015 Jul; 39(7):858-64. PubMed ID: 25712700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of technical failures on recombinant production of soluble proteins in Escherichia coli: a case study on process and protein robustness.
    Pekarsky A; Reininger M; Spadiut O
    Bioprocess Biosyst Eng; 2021 Jun; 44(6):1049-1061. PubMed ID: 33491129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.